News

Exclusive Model Home Now Available at Toll Brothers' River Terrace

Exclusive Model Home Now Available at Toll Brothers' River Terrace

Luxury Model Home Announcement from Toll Brothers

Toll Brothers, Inc., the premier builder of luxury homes in the nation, is thrilled to announce that its exquisite model home is now on the market at the Toll Brothers at River Terrace community. This two-story Gates Farmhouse model home, located in the beautiful Bull Mountain area, is one of only three remaining homes available in the community's popular Spring Collection, showcasing the elevated style and craftsmanship that the Toll Brothers brand is known for.

Experience Elegant Living at River Terrace

Nick Norvilas, the Division President for Toll Brothers in Oregon, shares, "The Gates Farmhouse model home is a perfect showcase of the innovative and luxurious designs Toll Brothers delivers at River Terrace. We are enthusiastic about offering home shoppers this opportunity to own a beautifully designed, professionally decorated residence in one of Tigard's most desirable neighborhoods."

Final Opportunity to Own at River Terrace

This community’s Spring Collection is in its closing opportunity, with only three quick move-in homes still for sale. This presents a unique chance for interested buyers to secure their place in the first phase of this remarkable development. The homes feature luxurious amenities, including 5 to 6 bedrooms, 3 to 5 bathrooms, and 2-car garages, alongside refined open-concept living spaces and sophisticated architectural details that make these homes truly stand out.

Quick Move-In Homes with Stunning Features

The available quick move-in homes have been thoughtfully designed to include outdoor living spaces, daylight basements, versatile lofts, main-floor bedrooms, and flexible living areas that cater to modern lifestyles. Prices for these final homes start from an impressive $1.074 million, reflecting the top-tier quality and craftsmanship of Toll Brothers properties.

Convenient Amenities and Vibrant Community

Residents will relish the vibrant downtown Tigard, known for its unique shopping and dining opportunities, as well as a delightful seasonal farmers market. The upscale Bridgeport Village shopping district and premier Washington Square shopping center add to the desirability of the location, providing easy access to retail and recreational amenities.

Recreational Opportunities Abound

Tigard is a hub of outdoor activities, including canoeing, fishing, and wildlife observation along the scenic Tualatin River. Within the master-planned River Terrace community, an extensive network of walking and biking trails offers residents easy access to area parks and open spaces, enhancing their lifestyle.

Contact Toll Brothers for More Information

The Toll Brothers at River Terrace community is conveniently located at 14995 SW 164th Ave in Tigard. For further details about the Spring Collection or to schedule a visit to learn more about the community and available homes, interested parties can call (844) 900-8655 or visit TollBrothersatRiverTerrace.com.

About Toll Brothers

Toll Brothers, Inc. has established itself as the leading luxury home builder across the United States since its founding in 1967. The company, traded on the New York Stock Exchange under the ticker symbol 'TOL', constructs homes in over 60 markets across 24 states. Its clientele spans first-time buyers to active adults and urban renters.

Frequently Asked Questions

What types of homes are available at Toll Brothers at River Terrace?

The community offers two- and three-story luxury homes with various configurations, including 5 to 6 bedrooms and 3 to 5 bathrooms, designed for modern living.

How much do the homes at River Terrace cost?

Prices for the final homes in the Spring Collection start from $1.074 million, reflecting the high-quality construction and luxury features.

Where is Toll Brothers at River Terrace located?

The community is situated at 14995 SW 164th Ave in Tigard, providing easy accessibility to surrounding cities and amenities.

Are there recreational facilities nearby?

Yes, residents can enjoy outdoor activities at the Tualatin River, along with access to parks and biking trails within the community's master plan.

How can I get more information about Toll Brothers homes?

For more information, you can call (844) 900-8655 or visit the official site, TollBrothersatRiverTerrace.com, for inquiries or to schedule an appointment.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LIV Golf's Big Play: Restructuring with Saudi PIF

Updated Category News Views 6

Trailblazing Change in the Golf World It's like watching a high-stakes game of chess where pieces are worth billions. White Knight Capital Corp. has thrown its hat into the ring with the Public Investment Fund of Saudi Arabia to overhaul LIV Golf Enterprises. This isn't your average Monday morning golf chat; it's full-on corporate drama with financial steroids. Debt Swap...

Continue Reading
Innovative SOV Launches for Offshore Wind Revolution

Updated Category News Views 2

A New Era for Offshore Wind Operations Mark my words, folks, this launch ain't just some minor milestone swaying gently on the industry seas. ZPMC's 'Wind of Ocean' is about to kickstart a whole new game in Europe's offshore wind space. Built with brains and brawn, this vessel embodies the future of sustainable and efficient offshore operations. The announcement from...

Continue Reading
MiniTool MovieMaker 8.9: Keyframe Animation Upgrade

Updated Category News Views 2

Breaking Down MiniTool MovieMaker 8.9's Revamp Kicking off the day with some noteworthy news in the creative software arena, MiniTool's latest update to its MovieMaker program is grabbing attention. It’s not often you hear software developers hitting the right balance between functionality and simplicity as they've done with this release. Keyframe Animation: The Star of...

Continue Reading
Fujifilm's New 400mm Lens: A Game Changer?

Updated Category News Views 1

Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...

Continue Reading
Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Updated Category News Views 1

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 2

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
Potomac Edison Eyes Rate Hike for System Overhaul

Updated Category News Views 0

FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...

Continue Reading
Pathlock Faces Identity Governance Opportunities in 2026

Updated Category News Views 3

Challenges in Identity Governance Emerge for 2026 Imagine a world where digital identities run wild—unmonitored, orphaned, dormant. Welcome to 2026, where identity governance and administration (IGA) face a reckoning, dragging enterprises into the spotlight as they scramble to protect against identity chaos. With Pathlock’s recent recognition in the Gartner Market...

Continue Reading
Reolink Unveils OMVI 2i Ultra at IFA 2026

Updated Category News Views 6

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Continue Reading
China's Diplomatic Dance: SCO Summit & Key Visits

Updated Category News Views 2

A Diplomatic Balancing Act Xi Jinping's recent diplomatic tour, climaxing at the Shanghai Cooperation Organization (SCO) Summit and extending through critical visits to Kyrgyzstan and Egypt, paints a compelling picture of China's strategic intentions. For those of us watching the geopolitical chessboard, it's like seeing a master strategist at work—pondering a tricky...

Continue Reading

Top 5 Most Recently Viewed Articles

Theravance Buyout Scrutinized: Is Zymeworks Deal Fair?

Updated Category News Views 6

Theravance and Zymeworks: What's the Deal? First things first, the numbers. Theravance Biopharma, the biotech entity waving its NASDAQ: TBPH ticker, is about to jump into bed with Zymeworks, another player in the pharma game. The pitch? One hundred seventy-six bucks a share in cold, hard cash, plus a contingent value right. That's right—sweet on paper, but always worth...

Continue Reading
Top Stock Split Opportunities for Maximum Growth Potential

Updated Category News Views 72

Stock splits surged back into the limelight recently, flipping the script on a strategy that had been gathering dust. Once thought outdated, these moves have become hot again, reflecting how companies with robust performances can maintain investor interest while managing share prices effectively. When you see a stock split, it’s often more than just a number game; it's...

Continue Reading
Roc Nation and Musicow: Pioneering a New Era in Music Equity

Updated Category News Views 455

Roc Nation Collaborates with Musicow for Music Equity Innovation Roc Nation has embarked on an exciting partnership with Musicow, a South Korean fintech firm. This collaboration aims to introduce the first Music Equity Service Provider (MESP) in the United States. By allowing music rights holders to buy, sell, and trade shares in music royalty revenue, this initiative...

Continue Reading
Latest Updates from the FDA: New Guidelines and Approvals

Updated Category News Views 396

Insights from Recent FDA Activities The U.S. Food and Drug Administration (FDA) has released an overview of recent important developments aimed at enhancing public health and safety. These updates offer invaluable information about various health issues, product approvals, and guidance to manufacturers. Investigation of E. coli Outbreak Recently, the FDA updated its...

Continue Reading
Insider Sale Sparks Interest in BorgWarner's Future Prospects

Updated Category News Views 173

Understanding Insider Transactions at BorgWarner Recently, a notable insider sale captured attention. Isabelle McKenzie, the Vice President of BorgWarner, made headlines when she sold 2,500 shares, totaling around $100,025. This transaction was officially reported in a filing to the SEC, particularly through a Form 4. Such insider activities often spark curiosity among...

Continue Reading